Medical device major, Medtronic plc MDT recently received the U.S. FDA 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. The device is an advanced cardiac ...

BRAMPTON, ON--(Marketwired - May 13, 2014) - Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable ...

AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM MedTech Breakthrough, an independent market intelligence organization ...

NICE, FRANCE – A small usability study testing a miniaturized implanted cardiac monitoring system (Reveal LINQ, Medtronic) in European patients shows the device successfully resulted in the wireless ...

DUBLIN, Medtronic plc today announced the first in-office implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study. The world's smallest cardiac ...

The University of Michigan Frankel Cardiovascular Center is one of the nation's first hospitals to use the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System, the smallest implantable ...

MINNEAPOLIS, MN — Both US and European regulators have cleared for use the Reveal LINQ insertable cardiac monitor (ICM) system (Medtronic), billed by the company as the world's smallest implantable ...

MINNEAPOLIS - February 19, 2014-Medtronic, Inc. (MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of its Reveal ...